BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis
Europe - BIT:1BAYN - DE000BAY0017 - Common Stock
26.47 EUR
-0.31 (-1.16%)
We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 53 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
In the past year 1BAYN was profitable.
1BAYN had a positive operating cash flow in the past year.
In multiple years 1BAYN reported negative net income over the last 5 years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1.2 Ratios
1BAYN has a worse Return On Assets (-3.25%) than 66.04% of its industry peers.
1BAYN has a Return On Equity of -11.25%. This is in the lower half of the industry: 1BAYN underperforms 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of 1BAYN has declined.
1BAYN has a worse Gross Margin (54.95%) than 69.81% of its industry peers.
1BAYN's Gross Margin has declined in the last couple of years.
1BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
1BAYN has about the same amout of shares outstanding than it did 5 years ago.
1BAYN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.78, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
1BAYN has a Altman-Z score of 0.78. This is in the lower half of the industry: 1BAYN underperforms 73.58% of its industry peers.
The Debt to FCF ratio of 1BAYN is 8.37, which is on the high side as it means it would take 1BAYN, 8.37 years of fcf income to pay off all of its debts.
1BAYN has a worse Debt to FCF ratio (8.37) than 67.92% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: 1BAYN underperforms 67.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.78 |
ROIC/WACCN/A
WACC6.4%
2.3 Liquidity
1BAYN has a Current Ratio of 1.13. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
1BAYN has a Current ratio of 1.13. This is in the lower half of the industry: 1BAYN underperforms 67.92% of its industry peers.
1BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
1BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.36%.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
Looking at the last year, 1BAYN shows a decrease in Revenue. The Revenue has decreased by -1.99% in the last year.
Measured over the past years, 1BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
3.2 Future
Based on estimates for the next years, 1BAYN will show a small growth in Earnings Per Share. The EPS will grow by 2.96% on average per year.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.11% yearly.
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.28, the valuation of 1BAYN can be described as very cheap.
1BAYN's Price/Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 96.23% of the companies in the same industry.
1BAYN is valuated cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 5.42.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 94.34% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, 1BAYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.28 | ||
| Fwd PE | 5.42 |
4.2 Price Multiples
75.47% of the companies in the same industry are more expensive than 1BAYN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 98.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.66 | ||
| EV/EBITDA | 8.76 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y2%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, 1BAYN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.99, 1BAYN is paying slightly less dividend.
With a Dividend Yield of 0.41, 1BAYN pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.69%
EPS Next 2Y-1.62%
EPS Next 3Y2%
BIT:1BAYN (11/5/2025, 7:00:00 PM)
26.47
-0.31 (-1.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.00B
Revenue(TTM)46.17B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.07 (9.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)-1.85%
PT rev (3m)0.79%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-9.06%
EPS NY rev (1m)0%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.28 | ||
| Fwd PE | 5.42 | ||
| P/S | 0.56 | ||
| P/FCF | 5.66 | ||
| P/OCF | 3.64 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.76 |
EPS(TTM)5.01
EY18.93%
EPS(NY)4.89
Fwd EY18.47%
FCF(TTM)4.67
FCFY17.66%
OCF(TTM)7.28
OCFY27.49%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number59.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.78 |
F-Score4
WACC6.4%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y10.7%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / 1BAYN.MI FAQ
What is the fundamental rating for 1BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.
What is the valuation status for 1BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.
Can you provide the profitability details for BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for BAYER AG-REG?
The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -5.97% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -3.69%.